Hormone replacement therapy after a diagnosis of breast cancer: Cancer recurrence and mortality (multiple letters)

Medical Journal of Australia

Volumn 178, Issue 8, 2003, Pages 412-413

  Hayes, Theresa M ^a   Underhill, Craig R ^a   Clarke, Kerrie ^a   Tattersall, Martin H N ^b   Durna, Eva M ^c   Wren, Barry G ^e   Heller, Gillian Z ^d   Leader, Leo R ^c   Sjoblom, Peter ^c   Eden, John A ^c  

^a Border Medical Oncology Australia   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL HOSPITAL FOR WOMEN   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE; TAMOXIFEN; VENLAFAXINE;

BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG SAFETY; HORMONE SUBSTITUTION; HUMAN; LETTER; LIFE EXPECTANCY; MENOPAUSAL SYNDROME; PROGNOSIS; THROMBOEMBOLISM;

EID: 0038299002     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05265.x     Document Type: Letter

References (0)